Press-release for stocks publishing date 2021 - 06

Prices are updated after-hours

| -68.98% | O: 1.69% H: 0.5% C: -3.17%
brazil approval

Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis
Published: 2021-06-01 (Crawled : 21:00) - globenewswire.com
NVS | News | $98.35 1.1% 0.0% 2.2M

| 12.19% | O: 0.85% H: 0.37% C: 0.02%
treatment fda fda approval children approval psoriasis plague

| -70.14% | O: 4.06% H: 3.76% C: 2.79%
initiated approval eflapegrastim

| -72.87% | O: 6.48% H: 12.99% C: 12.3%
treatment fda acquired fda approval approval

Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
Published: 2021-06-01 (Crawled : 11:00) - investor.alkermes.com
LLY | News | $732.2 -1.81% 0.18% 2.1M

| 270.01% | O: 0.29% H: 0.28% C: -0.95%
ALKS | $24.66 1.65% 1.62% 1.7M

| 7.01% | O: 0.79% H: 1.4% C: 1.31%
treatment fda schizophrenia fda approval approval

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.